{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:13:16Z","timestamp":1755216796862,"version":"3.43.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>When the COVID-19 epidemic occurred for the first time in December 2019, the governments worldwide took some restriction measures for slowing the spread of novel coronavirus. Eventually, there was a considerable decrease in volunteer blood donations. Regular transfusions and follow-up of patients with thalassemia major (TM) should be maintained during this period. It is possible that the treatment of the patients with TM may hinder due to the difficulty of reaching the treatment center and the difficulty of blood supply. Thus, in this study, we aimed to investigate whether there were any differences in the follow-up and treatment of the patients with TM during the outbreak.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>Sixty-one patients with TM who were followed up in our center without COVID-19 contact history and symptoms were included in this study. The demographic features and red blood cell volume per kilogram they received, pretransfusion hemoglobin, serum ferritin (SF) level, biochemical parameters, and transfusion interval were recorded. The difference between the arithmetic mean of the data before and during the pandemic was evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In this study, 61 patients with TM (32 males\/29 females, mean age 13.9\u00b16.8\u2009y) were evaluated. The mean pretransfusion hemoglobin value was 9.14\u00b10.77\u2009g\/dL and 8.87\u00b1 0.80\u2009g\/dL before and during the pandemic, respectively (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.023). There was no difference between before and during the pandemic concerning transfusion interval and transfusion volume. However, SF levels increased above 1000\u2009ng\/mL in 16.6% of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Although blood donation decreased significantly during the pandemic, it was observed in this study that the blood needs of patients with TM could be provided. The results of the SF level showed that the management of chelation therapy should be more meticulous. However, we should be ready for the challenges in the transfusion practice of patients with TM due to fluctuations in the COVID-19 pandemic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002016","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T23:08:02Z","timestamp":1607036882000},"page":"e1073-e1076","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 Pandemic and Thalassemia Major Patients: Transfusion Practice and Treatment Assessment"],"prefix":"10.1097","volume":"43","author":[{"given":"Yesim","family":"Oymak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba H.","family":"Karapinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"R3-20250804","first-page":"218","article-title":"The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: the personal experience and the international recommendations","volume":"91","author":"Canatan","year":"2020","journal-title":"Acta Biomed"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"102836","DOI":"10.1016\/j.transci.2020.102836","article-title":"Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia","volume":"4","author":"Yahia","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"R5-20250804","first-page":"1","article-title":"Blood management during the COVID-19 pandemic","volume":"7","author":"Tolich","year":"2020","journal-title":"Cleve Clin J Med"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"e2020046","DOI":"10.4084\/mjhid.2020.046","article-title":"Preliminary data on COVID-19 in patients with hemoglobinopathies: a multicentre ICET-a study","volume":"12","author":"de Sanctis","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00441844","article-title":"Neocytopheresis: a new approach for the transfusion of patients with thalassaemia major","volume":"145","author":"Triadou","year":"1986","journal-title":"Eur J Pediatr"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clinthera.2019.12.003","article-title":"Systematic literature review of the burden of disease and treatment for transfusion-dependent \u03b2-thalassemia","volume":"42","author":"Betts","year":"2020","journal-title":"Clin Ther"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/trf.14508","article-title":"Risks of red blood cell alloimmunization in transfusion-dependent \u03b2-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review","volume":"58","author":"Al-Riyami","year":"2018","journal-title":"Transfusion"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the centers for disease control and prevention (CME)","volume":"54","author":"Vichinsky","year":"2014","journal-title":"Transfusion"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/bjh.12340","article-title":"Assessment and management of iron overload in beta-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL project","volume":"161","author":"Piga","year":"2013","journal-title":"Br J Haematol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2011.08576.x","article-title":"Red cell alloimmunization in a diverse population of transfused patients with thalassaemia","volume":"153","author":"Thompson","year":"2011","journal-title":"Br J Haematol"},{"key":"R14-20250804","first-page":"54","article-title":"Managing the patient with haemoglobinopathy and multiple red cell antibodies","volume":"11","author":"Politis","year":"2016","journal-title":"Vox Sanguinis"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/trf.13440","article-title":"Class I and II HLA antibodies in pediatric patients with thalassemia major","volume":"56","author":"Yee","year":"2016","journal-title":"Transfusion"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-3148.2006.00656.x","article-title":"Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan","volume":"16","author":"Wang","year":"2006","journal-title":"Transfus Med"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V96.10.3369","article-title":"Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent","volume":"96","author":"Singer","year":"2000","journal-title":"Blood"},{"key":"R18-20250804","first-page":"50","article-title":"Red cell alloantibodies in patients with thalassemia","volume":"58","author":"Spanos","year":"1990","journal-title":"Vox Sang"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"102678","DOI":"10.1016\/j.transci.2019.102678","article-title":"Red cell alloimmunization in transfusion-dependent and transfusion-independent beta thalassemia: a review from the Eastern Mediterranean Region (EMRO)","volume":"58","author":"Al-Riyami","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0377-1237(11)80008-0","article-title":"Red cell alloantibodies in multiple transfused thalassaemia patients","volume":"67","author":"Chaudhari","year":"2011","journal-title":"Med J Armed Forces India"},{"author":"Cappellini","key":"R21-20250804","article-title":"COVID-19 and thalassemia: frequently asked questions, (version 2.0)"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous betathalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N Engl J Med"},{"key":"R23-20250804","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fmed.2020.00306","article-title":"Management of hemoglobin disorders during the COVID-19 pandemic","volume":"7","author":"Chowdhury","year":"2020","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:00:17Z","timestamp":1754341217000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,2]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002016","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2020,12,2]]},"assertion":[{"value":"2020-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}